A federal judge in New Jersey has dismissed on summary judgment a bellwether case against Merck & Co. in the mass litigation over Fosamax, an osteoporosis treatment that can lead to femur fractures.
*May exclude premium content
Already have an account? Sign In Now
Interested in customizing your subscription with Law.com All Access?
Contact our Sales Professionals at 1-855-808-4530 or send an email to firstname.lastname@example.org to learn more.